Biocept - Model NGS - Next-Gen Sequencing Lung Panel - Liquid Biopsy Biomarker
From Target Selector NGS Panels
Combining Biocept’s Liquid Biopsy biomarker testing expertise with Oncomine™ from Thermo Fisher Scientific’s next-generation sequencing and decision support resources.
-
Most popular related searches
Product Details
- Exclusive, targeted and actionable; approximately 70% of biomarkers investigated are based on NCCN Guidelines and/or FDA approved therapies
- Cost effective NGS-based solution
- Turn-around-time (7-10 days upon receipt of specimen in most cases)
- Specimen requirements: 8 mLs of peripheral blood in CEE-SURE™ or EDTA Tube
- Sensitivity: 96-99% (MAF ≥0.1%)
- Raw data file available for further research
Customer reviews
No reviews were found for Biocept - Model NGS - Next-Gen Sequencing Lung Panel - Liquid Biopsy Biomarker. Be the first to review!